These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 22484498

  • 1. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
    David S, Perkins RS, Fronczek FR, Kasiri S, Mandal SS, Srivastava RS.
    J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
    Trávníček Z, Matiková-Mal'arová M, Novotná R, Vančo J, Stěpánková K, Suchý P.
    J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
    [Abstract] [Full Text] [Related]

  • 3. New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands.
    Grau J, Noe V, Ciudad C, Prieto MJ, Font-Bardia M, Calvet T, Moreno V.
    J Inorg Biochem; 2012 Apr; 109():72-81. PubMed ID: 22387934
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
    Ludwig G, Kaluđerović GN, Rüffer T, Bette M, Korb M, Block M, Paschke R, Lang H, Steinborn D.
    Dalton Trans; 2013 Mar 21; 42(11):3771-4. PubMed ID: 23340605
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G, Kaluđerović GN, Bette M, Block M, Paschke R, Steinborn D.
    J Inorg Biochem; 2012 Aug 21; 113():77-82. PubMed ID: 22698819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
    Hanif M, Meier SM, Kandioller W, Bytzek A, Hejl M, Hartinger CG, Nazarov AA, Arion VB, Jakupec MA, Dyson PJ, Keppler BK.
    J Inorg Biochem; 2011 Feb 21; 105(2):224-31. PubMed ID: 21194622
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.